Skip to content
  • Brazil
  • Canada
  • Europe
  • India
  • Italy
  • Japan
  • Korea
  • Latam
  • Spain
  • Taiwan
  • The Middle East
  • Turkey
  • United Kingdom
  • United States
  • Brasil
  • Central de Atendimento +55 11 2500 1570 WhatsApp +55 11 9 7117 9759
  • PORTAL DE CLÍNICAS
  • Solicitar informação
  • Central de Atendimento +55 11 2500 1570 WhatsApp +55 11 9 7117 9759
  • Part of brands: |
Igenomix BrasilIgenomix Brasil
  • Part of brands: |
  • Patient Journey
    • Before Pregnant
    • IVF Process
    • Healthy pregnancy
    • After birth
  • SAÚDE REPRODUTIVA
  • SAÚDE GENÉTICA
  • Sobre nós
  • EVENTOS
  • Blog

Pesquisa científica Igenomix

Pesquisa Científica

A atividade da Fundação Igenomix envolve a investigação científica com enfoque dentro de diferentes fases da vidas, especialmente na medicina reprodutiva e doenças genéticas.

Nossas pesquisas incluem:

Pesquisas de base utilizadas para adquirir um novo conhecimento da biologia humana que abra caminhos para pesquisas relacionadas.

Projetos Translacionais como ensaios clínicos a partir dos avanços dos estudos básicos.

Protocolos Clínicos que tenham aplicabilidade imediata tanto no setor reprodutivo quanto na prática clínica de rotina.

Linhas de pesquisa

tumor uterino

Aymara Mas, PhD

Molecular and celular origin of gynecological tumors

Our previous work has demonstrated the genomic differential characterization of myomas and leiomyosarcomas.

We aim to shift the diagnostic and therapeutic focus of uterine leiomyomas and leiomyosarcomas through genomic characterization.

More information

Inmaculada Moreno, PhD

The endometrial microbiome in human reproduction

Our research group has described the existence of the endometrial microbiome and its clinical implications on the reproductive outcome.

We investigate the impact of uterine microbiome dysbiosis and its clinical impact.

More information

Felipe Vilella, PhD

Materno-embryonic communication

We have investigated how the mother communicates with the preimplantation embryo prior to implantation, and discovered that the maternal endometrium modifies the transcriptomics of the embryo in health and disease.

The language use in this dialogue is composed by extracellular vesicles, miRNA and DNA secreted by the endometrium to the endometrial fluid that is internalized by the embryo modifying its transcriptome.

More information

Xavier Santamaria MD, PhD

Adult stem cells in the human endometrium

We have identified the existence of human endometrial stem cells and have further clarified their origin from the endogenous source (endometrium) and from the bone marrow.

We have demonstrated the therapeutic potential of autologous bone marrow CD133+ stem cells in the treatment of non-curable endometrial pathologies such as Asherman’s syndrome or endometrial atrophy.

More information
PGT-A Igenomix

Carmen Rubio, PhD

The embryo as the patient

Our previous clinical research has already shown the benefits of preimplantation genetic testing for aneuploidies (PGT-A) to increase live birth rates and decrease miscarriages and time to pregnancy.

Now, we aim to develop a non-invasive approach to identify euploid embryos for transfer by assessing the cell-free DNA secreted by the embryo without the need for embryo biopsy.

More information
pre-eclampsia

Tamara Garrido, PhD

The maternal implication in the origin of pre-eclampsia

Preeclampsia is a major obstetric complication affecting 8% of first-time pregnancies with serious consequences for both mother and child. Despite years of investigations, its etiology remains elusive. The unsolved question is why shallow trophoblast invasion occurs, and we turned the attention to the maternal decidua. Our published studies evidenced for the first time a defective decidualization in the endometrium of women with preeclampsia, which is detected at the time of delivery and lingers for years afterwards. In this context, the major challenge is to elucidate the molecular mechanisms underlying this defect, as well as to delving into specific cell populations that may be altered in this syndrome.

More information
Atlas do ciclo menstrual

Carlos Simón MD, PhD / Felipe Vilella, PhD

Study of endometrial receptivity

We discovered the transcriptomic signature of human endometrial receptivity.

Now, we are focusing on a new, minimally invasive procedure using single-cell analysis.

More information

Felipe Vilella, PhD/Pradeep Reddy, PhD

Creation of artificial gametes by transdifferentiating human somatic cells

Creation of artificial gametes is a long-term goal in the field of infertility research.

Our lab has demonstrated the possibility of converting somatic cells into primordial germ cell-like cells by inducing the expression of germ cell genes.

More information

Colaborações

Some of the main collaborative projects with internationally-renowned centres include:

incliva

To promote the excellence and scientific leadership of this consolidated team, and pool efforts and technical resources, in 2017, the Igenomix Foundation entered into agreement with the University of Valencia and the Foundation of the Clinical Hospital of Valencia (INCLIVA) for the purpose of establishing the Collaborative Research Unit in Reproductive Medicine.

Study of transcriptomic modifications in human embryos produced by the miRNAs secreted by the maternal endometrium, in collaboration with Professor Barry Behr, Department of Gynaecology and Obstetrics, Stanford University, California, USA.

Study of the decidualization process in pre-eclampsia, with Dr. Susan Fisher from the Department of Obstetrics, Gynaecology and Reproductive Sciences, USCF (University of California San Francisco, California, USA).

Study of the origin of fetal diseases, in collaboration with Professor Guilliam Gibbons, Department of Gynaecology and Obstetrics, Baylor College, Texas, USA.

NÓS TE GUIAMOS

Fertilidade
Prevenção de doenças hereditárias
Gravidez saudável

TODOS OS SERVIÇOS

Genética Reprodutiva
Diagnóstico de Doenças Genéticas

SOBRE NÓS

Sobre a Igenomix
Laboratórios
Notícias
Qualidade
Trabalhe conosco
Como enviar uma amostra?

gestão de resíduos

SIGA-NOS

Blog: Caminho da Fertilidade

SELO ONA 2026

⬇️ Clique e confira o Certificado: 385-007-279

Instituição Acreditadora Credenciada Instituto Qualisa de
Gestão - IQG | Validade: 10/2026

Central de Atendimento Brasil: 11 2500 1570 WhatsApp: 11 9 7117 9759  atendimentoaocliente@igenomix.com

  • Brazil
  • Canada
  • Europe
  • India
  • Italy
  • Japan
  • Korea
  • Latam
  • Spain
  • Taiwan
  • The Middle East
  • Turkey
  • United Kingdom
  • United States
Idioma

Igenomix Brasil Laboratório de Medicina Genética LTDA |
CNPJ 19.555.576/0001-43 | Endereço Av. República do Líbano, 500 - 04502-000 | São Paulo - SP | Responsável Técnica: Paula Regina Queiroz Estrada CRbio 113829/01-D | email: infobrasil@igenomix.com

[2024] © Igenomix Política de qualidade Política de Privacidade  Nota legal Política de cookies Direitos do Paciente

Contato



  • Patient Journey
    • Before Pregnant
    • IVF Process
    • Healthy pregnancy
    • After birth
  • SAÚDE REPRODUTIVA
  • SAÚDE GENÉTICA
  • Sobre nós
  • EVENTOS
  • Blog
  • Brasil
  • PORTAL DE CLÍNICAS
  • Central de Atendimento +55 11 2500 1570 WhatsApp +55 11 9 7117 9759